LATEST WEBINARS
Available to view on demand
In this panel discussion our experts will analyze the results from our recent survey on the bioanalysis of biopharmaceuticals and biomarkers, providing a comprehensive overview and focusing on developing technologies and trends.
Available to view on demand
In this mini-webinar you will learn about different LC-MS/MS approaches for quantitative protein bioanalysis with focus on biopharmaceuticals, biomarkers and targeted proteomics.
Available to view on demand
Attendees will learn our laboratory’s approach for designing, calibrating, and implementing protein quantitation assays in proteomics.
Available to view on demand
Our experts discuss what the future holds for outsourcing in the next ten years and the implications this will have on the industry for CRO and Pharma.
Available to view on demand
Avoid preclinical testing failure by understanding the complex bioanalytical and toxicology challenges associated with ADC drug development and unique ways to overcome them.
Join us for a lively panel discussion with leading experts in the field to further discuss what the progress of microsampling over the years has meant for the community, address remaining challenges still being faced and how to overcome these.
Learn how MSIA provides a simple and effective automated workflow for the measurement of Antisense ODN activity for the treatment of amyliodosis via the measurement of TTR expression.
Bioanalytical assays are essential in drug development. In recent years, many new technologies have emerged which offer scientists throughput, sensitivity, multiplexing, and the ability to better understand the data.
This presentation will review the challenges and misconceptions surrounding implementation of microflow LC/MS into a bioanalytical workflow.
Latest News
PerkinElmer aims to expand their reach into the autoimmune and allergy diagnostic market through a $1.3 billion acquisition of EUROIMMUN.
Scientists from the University at Albany (NY, USA) have published their findings on a method that could accurately predict the age of bloodstains at crime scenes for up to 2 years.
Thermo Fisher Scientific Inc. (MA, USA) have announced new technologies that obtain high-resolution separations with increased sensitivity and reproducibility.
Latest Features
In this commentary, Kate Peng discusses the current thinking on quantification of protein therapeutic pharmacokinetics and protein biomarkers in clinical studies.
In this interview Ian Moore, Global Technical Marketing Manager at Sciex (Toronto, Canada), gives his insight into the innovations and challenges he has faced whilst working in drug development.
View some of the poster presentations delivered at this years 11th WRIB conference.
Automation
Novel inertial microfluidic device could enhance sorting and purification of cells
Automation in Chinese bioanalytical CROs for sustained competitiveness and growth
Chromatography
Researchers identify candidate biomarkers for onset of osteoporosis
Could metabolomic profiling lead to earlier diagnosis of H1N1 influenza pneumonia?
Clinical
Could DNA barcoding be the key to detecting cancer earlier?
Collaborations and Mergers
PerkinElmer increases diagnostic capacities with acquisition of EUROIMMUN for $1.3 billion
Charles River partners with OcellO to expand oncology business
Data Processing / Interpretation
Thermo Fisher Scientific announce two new technologies to increase analytical accuracy
Drug Discovery and Development
‘Heart-on-a-chip’ engineered by Lawrence Livermore researchers
Could a blood test predict the outcome of prostate cancer treatment?
Forensic
Forensic scientists develop a new technique to distinguish the origins of bodily fluids
Disease pathogens rapidly detected by new test
Fingerprints: biological samples for identification of sex and, potentially, more
Imaging
Could chemiluminescence detect cancer?
Lung cancer recurrence detected earlier by circulating tumor cell test
Brain tumor progression and response to treatment tracked by new imaging biomarker
Ligand-binding
Mass Spectrometry
Insulin bioanalysis workflows simplified by new ready-to-use mass spectromic kit
Researchers identify candidate biomarkers for onset of osteoporosis
Could metabolomic profiling lead to earlier diagnosis of H1N1 influenza pneumonia?
Other
Poster presentations from the 11th Workshop on Recent Issues in Bioanalysis (WRIB)
BioPharmaSpec announce new in-house analytical services
TRUE-AHF is latest CRO-led international clinical trial reported to lack integrity
Regulated Bioanalysis
Study shows similarity in efficacy and safety between trastuzumab and its biosimilar candidate
FDA approval for first cancer treatment targeting solid tumors based on genetic characteristics
Pfizer’s proposed biosimilar secures approval from FDA advisory committee
Sample preparation, extraction & collection
Could a blood test accurately predict Autism?
Sports Drug Testing
Microsampling in sports drug testing – an interview with Laura Mercolini (University of Bologna)
Q&A With Monica Mazzarino & Franscisco Radler on key anti-doping issues
Toxicology
Bioanalysis and toxicology challenges with ADC: how are they different and new?